Invited Speaker

  1. Invited Speaker, International Oncology Symposium, Hospital Porto Dias, Brazil, November 13, 2021
  2. Invited Speaker, 1st International Genitourinary Cancer Conference (IGCC), Jeddah, Saudi Arabia, November 5-6, 2021
  3. Invited Speaker, V GU Review – LACOG-GU Symposium, October 14, 2021
  4. Invited Speaker, 12th Muscat International Oncology Online Conference, National Oncology Center, Royal Hospital, October 9, 2021
  5. Session Chair and Invited Speaker, Precision Oncology Summit. Binaytara Foundation. Salt Lake City, UT, October 3, 2021
  6. Invited Speaker, 2021 ESMO Annual meeting. Oral presentation, abstract # LBA24, Paris, France, September 17, 2021
  7. Invited Speaker, Advancement in Treatment for mCSPC, 1st Annual Advances in Men’s Health, Whitefish, MT, August 25, 2021
  8. Invited Speaker, GU Malignancies, ASCO Direct Highlight: 2021 Official Annual Meeting Review, Seattle, WA, July 25, 2021
  9. Invited Speaker, Genitourinary Cancer – Prostate Update, Genitourinary Cancer Session at the Virtual ASCO Direct Denver program, Denver, CO, July 18, 2021
  10. Invited Speaker, Recent Advancement in the Treatment of Metastatic Castration Sensitive Prostate Cancer (mCSPC) and Real World Utilization of Guideline Based Therapy in mCSPC: Update from the 2021 ASCO Annual Meeting, 31st Annual International Prostate Cancer Update (IPCU), Snowbird, UT, July 16, 2021
  11. Invited Speaker, Highlights in Genitourinary Cancers, PER’s ASCO Direct Highlight, Las Vegas, Nevada, June 26, 2021
  12. Invited Speaker, 2021 ASCO Annual Meeting. Oral presentation, abstract #5001, June 5, 2021
  13. Invited Speaker, Targeting DNA damage Response Pathways in Prostate Cancer, Hematology-Oncology Fellows Conference & Grand Rounds, Mt. Sinai, NYC, May 13, 2021
  14. Invited Speaker, Metastatic Castration-Sensitive Prostate Cancer: Recent Strides in Drug and Biomarker Development, Grand Rounds, Taussig Cancer Center, Cleveland Clinic, April 9, 2021
  15. Invited Speaker, Metastatic Castration Sensitive Prostate Cancer: Recent Strides in Drug and Biomarker Development, Hematology-Oncology, Grand Rounds, Stephenson Cancer Center, University of Oklahoma, March 19, 2021.
  16. Invited Speaker, Metastatic Castration Sensitive Prostate Cancer, Institutional Perspective on Prostate Cancer, University of Washington, OncLive State of Science Summit, November 24, 2020.
  17. Invited Speaker, Emerging Role of PARP Inhibitors in Prostate Cancer, Prime Oncology CME, Prime Education LLC, Fort Lauderdale, FL (Virtual), October 31, 2020.
  18. Invited Speaker, The Universe of Castration Sensitive Prostate Cancer, UroTarget 2020, Argentina Oncology Association (AAOC), October 31, 2020.
  19. Invited Speaker, Updates in the Management of Advanced Prostate Cancer and Personalizing Therapy, Grand Rounds, Fred Hutchinson Cancer Research Center, University of Washington, October 5, 2020.
  20. Invited Speaker, Updates in Prostate Cancer, ASCO Direct UAE 2020 Webinar, Genitourinary Oncology, Emirates Oncology Society, Abu Dhabi, UAE, October 3, 2020.
  21. Invited Speaker, Opinions in Bladder Cancer, Curio Science, Denver CO (Virtual), September 30, 2020.
  22. Invited Speaker, Systemic Therapy of Low Volume Metastatic Castration Sensitive Prostate Cancer, ONCO 2020, Society of Urology of Columbian/Ecuador/Peru, September 25, 2020.
  23. Invited Speaker, National Congress, Molecular Medicine from Laboratory to Practice, Athens, Greece. March 12, 2020.
  24. Invited Speaker, Tata Memorial Centre, 18th Annual Conference on Evidence Based Management of Cancers in India, Uro Oncology- Decade of Transformation, Mumbai, India. February 28-March 1, 2020.
  25. Oral Presentation, 2020 Genitourinary Cancer Symposium (GU ASCO). Time to Second Progression (PFS2) in Patients From TITAN With Metastatic Castration-Sensitive Prostate Cancer by First Subsequent Therapy (Hormonal vs Taxane). San Francisco, CA. February 13, 2020.
  26. Oral Presentation, Health Related Quality of Life with Apalutamide in Phase 3 Titan trial. 11th European Multidisciplinary Congress in Urologic Cancers (EMUC), Vienna, Austria, November 16, 2019.
  27. Invited Speaker, OnConnect (9th PCF) meeting. Sao Paulo, Brazil, August 16-17, 2019.
  28. Invited Speaker, Oncology Grand Rounds. Saint Vincent’s Medical Center. Immunotherapeutic Strategies for Advanced Renal Cell Carcinoma.Bridgeport, CT.August 30, 2019.
  29. Invited Speaker, Grand Rounds, Department of Internal Medicine, University of Utah, July 18, 2019.
  30. Invited Speaker, Science Friday/ SciFri (with Ira Flatow), New York Public Radio. Making Cancer Drugs Available For A Wider Pool Of Patients. 06/07/2019. Web Link: https://www.sciencefriday.com/segments/making-cancer-drugs-available-for-a-wider-pool-of-patients/
  31. Oral Presentation, 2019 ASCO Annual Meeting – Balancing Disease Control and Quality of Life in Metastatic Renal Cell Carcinoma. Chicago, IL. June 3, 2019.
  32. Invited Speaker and Panelist, Juravinski and Walker Cancer Centres Uro-oncology Forum 2019. Niagra-On-The-Lake, ON, Canada. March 2, 2019.
  33. Invited Speaker, Canadian Urology Association. Grand Round talks at McGill University Health Centre (MUHC), Centre hospitalier de I’Universite de Montreal (CHUM), Jewish Gerneral Hospital, London Regional Cancer Centre, Princess Margaret Cancer Centre (UHN). 2/27/19-3/01/19.
  34. Invited Speaker and Chair, OncLive State of Science Summit, Motif Seattle. Seattle, WA. 12/13/18.
  35. Invited Speaker, Cardinal Health Oncology Summit. Orlando, FL. November 11, 2018.
  36. Invited Speaker and Session Moderator, 17th International Kidney Cancer Symposium, Kidney Cancer Association. Miami, FL. November 2-3, 2018.
  37. Oral Presentation, 17th International Kidney Cancer Symposium, Kidney Cancer Association. CfDNA. Miami, FL. November 2, 2018.
  38. Oral Presentation, 17th International Kidney Cancer Symposium, Kidney Cancer Association. Phase 1b Study (COSMIC-021) of Cabozantinib in Combination with Atezolizumab: Results of the Dose Escalation Stage in Patients with Treatment-Naïve Advanced Renal Cell Carcinoma (RCC). Miami, FL. November 3, 2018.
  39. Oral Presentation, European Society of Medical Oncology (ESMO) 2018 Congress – Proffered (oral) Paper session, Translational Research Session- Pan-cancer assessment of BRCA1/2 genomic alterations (GAs) by comprehensive genomic profiling (CGP) of tissue and circulating tumor DNA (ctDNA) (abstract 51O). Munich, Germany. October 20, 2018.
  40. Invited Speaker and Session Chair, 2018 American Society of Clinical Oncology (ASCO 2018) Annual Meeting – Prostate Cancer Tumor Board, Education Session, Chicago, IL. June 4, 2018.
  41. Invited Speaker, 2018 ASCO Pre-Annual Meeting Seminar Faculty Invitation – Cancer Immunotherapy Today: Maximizing Patient Outcomes. Immunotherapy Update in Genitourinary Oncology. June 1st, 2018.
  42. Invited Speaker and Chair, 2018 Huntsman Cancer Institute Genitourinary Oncology Symposium, Salt Lake City, UT, May 25, 2018.
  43. Invited Speaker and Chair, OncLive State of Science Summit, Little America Hotel, Salt Lake City, UT, May 24, 2018.
  44. Invited Speaker, Targeted Oncology Conference, Napa, CA. March 16, 2018.
  45. Invited Speaker, American Society of Clinical Onocolgy (ASCO) University Faculty Speaker (webcast), February 2018: Treatment of Castration Sensitive Metastatic Prostate Cancer.
  46. Invited Speaker, Grand Rounds, Division of Nephrology and Hypertension, University of California, Irvine. November 27, 2017.
  47. Invited Speaker, 8th SOGUG (Spanish Genitourinary Oncology Group) Science Meeting, Madrid, Spain. November 17, 2017.
  48. Invited Speaker, Cardinal Health Science Summit, Phoenix, AZ. November 11, 2017.
  49. Invited Speaker and Panel Member, Medical Crossfire, 2017 Chemotherapy Foundation Symposium (Greenspan Meeting), New York City, NY. November 10, 2017.
  50. Invited Speaker and Panel Member, City of Hope Cancer Center Grand Rounds: Update on Genitourinary Cancers. Duarte, CA. November 7, 2017.
  51. Invited Speaker and Panel Member, Onclive State of Science Summit, Los Angeles, CA. November 6, 2017.
  52. Invited Speaker and Panel Member, 16th International Kidney Cancer Symposium, Miami, FL. November 3-4, 2017.
  53. Invited Speaker, 2017 American Society of Clinical Oncology (ASCO 2017) annual meeting- Education Session, Chicago, IL. June 3rd, 2017.
  54. Invited Speaker, 2017 American Endocrine Society (ENDO 2017) annual meeting, Orlando, FL. April 2nd, 2017.
  55. Invited Speaker and Panel Member, University of Utah School of Medicine Seminar, “How to Succeed in Research.” February 13th, 2017.
  56. Invited Speaker, 17th Annual Meeting of the Society of Urologic Oncology (SUO), San Antonio, TX, December 1, 2016.
  57. Invited Speaker, 15th International Kidney Cancer Symposium (IKCS meeting), Miami, FL, November 4, 2016.
  58. Invited Speaker, Cancer Biology Seminar Series, University of California Davis Comprehensive Cancer Center, Sacramento, CA. August 18, 2016.
  59. Invited Speaker, Discussant of oral abstract session, 2016 Genitourinary Cancers Symposium (GU-ASCO), San Francisco, CA. January 9, 2016.
  60. Invited Speaker, Society of Urologic Oncology (SUO) meeting, 16th Annual meeting, Washington DC. December 4, 2015.
  61. Invited Speaker, 14th International Kidney Cancer Symposium (IKCS meeting), Miami, FL. November 6, 2015.
  62. Invited Speaker, Fall Utah Urologic Summit, University of Utah, Park City, Utah, September 26, 2015.
  63. Invited Speaker, Cancer Center Grand Rounds, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. May 8, 2015.
  64. Invited Speaker, XXI Rio Journey of Urology, Brazilian Society of Urology, Rio de Janeiro, Brazil, November 19, 2014.
  65. Invited Speaker, Fall Utah Urologic Summit, University of Utah, Park City, Utah, September 28, 2014.
  66. Invited Speaker, Scripps Clinic 11th Annual Oncology Update, Las Vegas, NV, August 9, 2014.
  67. Invited Speaker, Cancer Center Grand Rounds, City of Hope Comprehensive Cancer Center. Duarte, CA. September 24, 2013.
  68. Invited Speaker, Grand Rounds, Department of Internal Medicine, University of Utah, July 30, 2009.
  69. Invited Speaker, MD Anderson Cancer Center “9th Annual Oncology Update: Advances and Controversies”, Park City, Utah. January 18, 2008.
  70. Invited Speaker, National Institute of Health-National Institute of Aging (United States, NIH-NIA), Anemia in Aging Workshop, Bethesda, MD. September 22, 2008.
  71. Invited Speaker, Utah Urologic Society Annual Meeting, Salt Lake City, Utah. February, 2008.
  72. Invited Speaker, Grand Rounds, Division of Geriatrics and Center of Aging, University of Utah, October 14, 2008.
Follow me on Twitter
%d bloggers like this: